Bank of Montreal
AUPH icon

Bank of Montreal’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bank of Montreal’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,108
Closed -$527K – 4144
2021
Q4 		$527K Buy
+23,108
New +$548K ﹤0.01% 2345
2021
Q3 		– Sell
-288,637
Closed -$3.89M – 3806
2021
Q2 		$3.89M Sell
288,637
-15,701
-5% -$200K ﹤0.01% 1719
2021
Q1 		$3.94M Buy
304,338
+10,425
+4% +$151K ﹤0.01% 1459
2020
Q4 		$4.15M Sell
293,913
-2,655
-0.9% -$38.6K ﹤0.01% 1496
2020
Q3 		$4.51M Buy
296,568
+82,993
+39% +$1.2M ﹤0.01% 1257
2020
Q2 		$3.26M Buy
213,575
+211,063
+8,402% +$3.38M ﹤0.01% 1383
2020
Q1 		$36K Sell
2,512
-2,188
-47% -$38.6K ﹤0.01% 3022
2019
Q4 		$95K Sell
4,700
-13,796
-75% -$127K ﹤0.01% 3524
2019
Q3 		$98K Sell
18,496
-1,300
-7% -$7.87K ﹤0.01% 3312
2019
Q2 		$131K Buy
19,796
+1,638
+9% +$10.4K ﹤0.01% 3172
2019
Q1 		$118K Sell
18,158
-68,250
-79% -$453K ﹤0.01% 2987
2018
Q4 		$589K Sell
86,408
-2,587
-3% -$14.9K ﹤0.01% 2098
2018
Q3 		$591K Sell
88,995
-11,935
-12% -$66.9K ﹤0.01% 2261
2018
Q2 		$568K Sell
100,930
-30,100
-23% -$168K ﹤0.01% 2276
2018
Q1 		$680K Buy
131,030
+38,570
+42% +$206K ﹤0.01% 2084
2017
Q4 		$419K Sell
92,460
-34,852
-27% -$193K ﹤0.01% 2367
2017
Q3 		$798K Buy
127,312
+40,612
+47% +$256K ﹤0.01% 2077
2017
Q2 		$532K Sell
86,700
-38,000
-30% -$256K ﹤0.01% 2244
2017
Q1 		$915K Buy
124,700
+117,200
+1,563% +$541K ﹤0.01% 1890
2016
Q4 		$23K Hold
7,500
– – ﹤0.01% 3353
2016
Q3 		$23K Hold
7,500
– – ﹤0.01% 3296
2016
Q2 		$21K Hold
7,500
– – ﹤0.01% 3360
2016
Q1 		$22K Hold
7,500
– – ﹤0.01% 3361
2015
Q4 		$19K Buy
+7,500
New +$20.4K ﹤0.01% 3413
2015
Q1 		– Sell
-12,500
Closed -$46K – 3966
2014
Q4 		$46K Hold
12,500
– – ﹤0.01% 3081
2014
Q3 		$40K Buy
+12,500
New +$44.4K ﹤0.01% 3221

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of Montreal's AUPH Position: Q1 2022 in Review

Bank of Montreal sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2022, closing a stake of 23,108 shares — an estimated $527K sold.

Bank of Montreal first reported a position in AUPH in Q3 2014 and held it in 26 quarters. The position peaked at $4.51M in Q3 2020. 184 funds tracked by Wall St. Rank hold AUPH as of Q1 2022.

  • Bank of Montreal reported no remaining Aurinia Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Bank of Montreal sold 23,108 Aurinia Pharmaceuticals shares in Q1 2022, an estimated $527K.
  • Bank of Montreal first reported a position in Aurinia Pharmaceuticals in Q3 2014 and held it in 26 quarters.
  • Bank of Montreal's Aurinia Pharmaceuticals position peaked at $4.51M in Q3 2020.
  • 184 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2022.

Based on Bank of Montreal's 13F filing for Q1 2022, filed 12 May 2022.